JP2005508323A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508323A5 JP2005508323A5 JP2003530220A JP2003530220A JP2005508323A5 JP 2005508323 A5 JP2005508323 A5 JP 2005508323A5 JP 2003530220 A JP2003530220 A JP 2003530220A JP 2003530220 A JP2003530220 A JP 2003530220A JP 2005508323 A5 JP2005508323 A5 JP 2005508323A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- pharmaceutical composition
- paclitaxel
- carboplatin
- chemotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 229930012538 Paclitaxel Natural products 0.000 claims 11
- 229960001592 paclitaxel Drugs 0.000 claims 11
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 11
- 229960004562 carboplatin Drugs 0.000 claims 9
- 190000008236 carboplatin Chemical compound 0.000 claims 9
- 238000002512 chemotherapy Methods 0.000 claims 9
- 229940123237 Taxane Drugs 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 229910052697 platinum Inorganic materials 0.000 claims 7
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 7
- 102100037850 Interferon gamma Human genes 0.000 claims 5
- 108010074328 Interferon-gamma Proteins 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 230000003442 weekly effect Effects 0.000 claims 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 2
- 229960004316 cisplatin Drugs 0.000 claims 2
- 229960003668 docetaxel Drugs 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 229940074404 sodium succinate Drugs 0.000 claims 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 claims 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- 229960001855 mannitol Drugs 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 229940068977 polysorbate 20 Drugs 0.000 claims 1
- 239000008223 sterile water Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32524601P | 2001-09-26 | 2001-09-26 | |
| PCT/US2002/030621 WO2003026581A2 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical compositions and methods for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508323A JP2005508323A (ja) | 2005-03-31 |
| JP2005508323A5 true JP2005508323A5 (enExample) | 2006-01-05 |
Family
ID=23267053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530220A Withdrawn JP2005508323A (ja) | 2001-09-26 | 2002-09-26 | 癌治療のための医薬組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040191218A1 (enExample) |
| EP (1) | EP1435965A4 (enExample) |
| JP (1) | JP2005508323A (enExample) |
| AU (1) | AU2002337713A1 (enExample) |
| WO (1) | WO2003026581A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080213399A1 (en) * | 2005-02-03 | 2008-09-04 | Topotarget Uk Limited | Combination Therapies Using Hdac Inhibitors |
| DK2073837T3 (da) * | 2006-10-06 | 2014-09-29 | Bavarian Nordic Inc | Rekombinant modificeret vaccinia-ankara-virus, der koder for et her-2-antigen, i kombination med en taxan til anvendelse til behandling af cancer |
| RU2346692C2 (ru) * | 2007-03-29 | 2009-02-20 | Ефаг АО | Применение 9-оксоакридин-10-уксусной кислоты, ее солей и сложных эфиров в комбинированной терапии рака яичников, способ лечения и наборы |
| CA2966216A1 (en) * | 2014-11-14 | 2016-05-19 | Genentech, Inc. | Predicting response to a vegf antagonist |
| CN108143714A (zh) * | 2016-04-12 | 2018-06-12 | 夏建明 | 一种用于治疗晚期卵巢癌的注射液及其制备方法 |
| CN105726475B (zh) * | 2016-04-12 | 2018-05-04 | 青岛市妇女儿童医院 | 一种治疗晚期卵巢癌的注射液及其制备方法 |
| EP4571309A1 (en) * | 2022-08-10 | 2025-06-18 | Nihon University | Sample test method, test kit for gynecological cancer and precancerous lesion thereof, and medicine |
| JP7716691B2 (ja) * | 2022-08-10 | 2025-08-01 | 学校法人日本大学 | 試料の検査方法、婦人科癌及びその前癌病変の検査キット及び医薬 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH588505A5 (enExample) * | 1972-06-08 | 1977-06-15 | Research Corp | |
| US4657927A (en) * | 1978-05-04 | 1987-04-14 | Research Corporation | Malonato platinum compounds |
| US4942184A (en) * | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
| US5440056A (en) * | 1992-04-17 | 1995-08-08 | Abbott Laboratories | 9-deoxotaxane compounds |
| CA2086874E (en) * | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
-
2002
- 2002-09-26 AU AU2002337713A patent/AU2002337713A1/en not_active Abandoned
- 2002-09-26 US US10/490,791 patent/US20040191218A1/en not_active Abandoned
- 2002-09-26 WO PCT/US2002/030621 patent/WO2003026581A2/en not_active Ceased
- 2002-09-26 EP EP02773602A patent/EP1435965A4/en not_active Withdrawn
- 2002-09-26 JP JP2003530220A patent/JP2005508323A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007515469A5 (enExample) | ||
| JP2012506448A5 (enExample) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| RU2017132877A (ru) | Комбинация антагониста pd-1 и эрибулина для лечения рака | |
| RU2012106620A (ru) | Комбинации и способы введения терапевтических средств и комбинированной терапии | |
| JP2012067116A5 (enExample) | ||
| JP2006515883A5 (enExample) | ||
| PT2127652E (pt) | Agente libertador da hormona estimuladora dos folículos | |
| RU2004115110A (ru) | Улучшенная схема применения противоопухолевого соединения в терапии рака | |
| JP2011140521A (ja) | タキサンにより惹起される神経毒性を予防又は軽減するための薬剤 | |
| JP2020523356A5 (enExample) | ||
| JP2014511383A5 (enExample) | ||
| RU2008138560A (ru) | Улучшенные способы лечения опухолей | |
| JP2017516802A5 (enExample) | ||
| RU2005141408A (ru) | Комбинированное применение эктеинасцидина-743 и содержащих платину противоопухолевых соединений | |
| JP2009539994A5 (enExample) | ||
| JP2018531605A5 (enExample) | ||
| JP2005508323A5 (enExample) | ||
| JP2008540364A5 (enExample) | ||
| Kobayashi et al. | Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan | |
| JP2005525409A5 (enExample) | ||
| JP2006514681A5 (enExample) | ||
| JP2008517991A5 (enExample) | ||
| CA2435921A1 (en) | Method of cancer therapy | |
| JP2009539916A5 (enExample) |